On October 9, 2014, the Pharmaceutical Research and Manufacturers of America (PhRMA), a drug industry group, filed a new complaint in the U.S. District Court for the District of Columbia in its continued challenge to the validity of the agency's interpretation of the orphan drug rule. Pharm. Research & Mfrs. of Am. v. HHS,D.D.C., No. 1:14-cv-01685. The latest complaint is available here.